These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11915744

  • 1. [Tumor marker in ovarian cancer].
    Komai K, Nishida T.
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [Abstract] [Full Text] [Related]

  • 2. [15 years CA-125 antigen: usefulness and limits. Apropos of 3 clinical cases].
    Petignat P, Vajda D, Obrist R.
    Praxis (Bern 1994); 1998 Nov 19; 87(47):1602-5. PubMed ID: 9865132
    [Abstract] [Full Text] [Related]

  • 3. [The sensitivity of the CA125 immunoradiometric assay for patients with epithelial ovarian cancer and its correlation with complex treatment].
    Shi W, Zhang YJ, Jiang CY.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Oct 19; 29(10):604-6, 637-8. PubMed ID: 7712875
    [Abstract] [Full Text] [Related]

  • 4. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K, Bian M, Zhu D, Liu W, Siu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr 19; 17(2):128-32. PubMed ID: 7656393
    [Abstract] [Full Text] [Related]

  • 5. [-CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-].
    Nagele E, Kurz C, Speiser P, Vavra N, Sevelda P.
    Geburtshilfe Frauenheilkd; 1996 Feb 19; 56(2):79-82. PubMed ID: 8647363
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I, Sarandakou A, Sikiotis K, Rizos D, Kalambokis D, Zourlas PA.
    Anticancer Res; 1996 Feb 19; 16(6B):3827-31. PubMed ID: 9042265
    [Abstract] [Full Text] [Related]

  • 7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 19; 14(2):306-18. PubMed ID: 15734951
    [Abstract] [Full Text] [Related]

  • 8. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 19; 43(1):5-8. PubMed ID: 18366923
    [Abstract] [Full Text] [Related]

  • 9. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M, Santala M, Risteli J, Risteli L, Kauppila A.
    Anticancer Res; 2000 Jan 19; 20(6C):4655-60. PubMed ID: 11205196
    [Abstract] [Full Text] [Related]

  • 10. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM, Sørensen JB, Lund BA.
    Ugeskr Laeger; 1998 Feb 09; 160(7):995-1000. PubMed ID: 9477746
    [Abstract] [Full Text] [Related]

  • 11. [CA-125 antigen].
    Zakrzewska I.
    Postepy Hig Med Dosw; 2002 Feb 09; 56(1):29-38. PubMed ID: 11987487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L, Sun J, Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb 09; 33(2):92-4. PubMed ID: 10682428
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Application of multi-tumor markers in ovarian carcinoma].
    Feng J, Qian H, Tian Y.
    Zhonghua Fu Chan Ke Za Zhi; 1998 May 09; 33(5):284-6. PubMed ID: 10682440
    [Abstract] [Full Text] [Related]

  • 20. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B, Calabretta F, Alghisi F, Salesi N, Bossone G.
    Minerva Ginecol; 2003 Aug 09; 55(4):327-32. PubMed ID: 14581857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.